Breast cancer is regarded as as a fatal disease and it is famous to be the number one cause of cancer fatality among women. According to American cancer society, about 1.3 million new breast cancer cases are detected on an annual basis which consists of 465,000 deaths. In order to productively tackle this disturbing disease, we should push revolutionary scientists to study cancer at its most basic stage. In other words, breast cancer research work must be conducted at its molecular stage. Also, besides the governments, private organizations should offer flexible budget to scientists who will be conducting breast cancer research work.
Appropriate funding of breast cancer investigation projects; can not only lead to improved prevention methods but it can also help towards earlier diagnostic techniques and new anticancer medication and treatments.
Recently, scientists who are working about breast cancer research project, have created and successfully tested a breast cancer vaccine which is possibly to cure women with treatment - resistant HER2 - positive breast cancer and therefore be able to avoid cancer re ? occurrence. Breast cancer scientists anticipate to use HER2 DNA vaccines for cancer-free women, in order to prevent initial development of such tumours. Today therapies such as trastuzumab and lapatimib are utilized in treating breast cancer patients. But, it was recently observed that a big group of patients build up a resistance towards trastuzumab and lapatimib. HER2 receptors are known to endorse a specifically aggressive kind of cancer that affects an estimated thirty percent of breast cancer patients. The latest breast cancer vaccine is produced by the body's own cells. It gives a cancer fighting gene into cells, which then form immune system proteins and also tumour ? destroying cells.
According to the primary researcher Wei - Zen Wei, a professor of immunology and microbiology at the Karmanos Cancer Institute, the vaccine is made by using so - called naked DNA from genes that produces the HER2 receptor. This DNA is mixed with an immune stimulant. The process involved in the production of the vaccine, is named as electro oration.
In this method, pulses of electricity were used in order to inject the vaccine into the leg muscles in rats. The genes moved towards the cells, which then produced HER2 receptors that directed to activation of antibodies and immune cells called Killer T cells.
Appropriate funding of breast cancer investigation projects; can not only lead to improved prevention methods but it can also help towards earlier diagnostic techniques and new anticancer medication and treatments.
Recently, scientists who are working about breast cancer research project, have created and successfully tested a breast cancer vaccine which is possibly to cure women with treatment - resistant HER2 - positive breast cancer and therefore be able to avoid cancer re ? occurrence. Breast cancer scientists anticipate to use HER2 DNA vaccines for cancer-free women, in order to prevent initial development of such tumours. Today therapies such as trastuzumab and lapatimib are utilized in treating breast cancer patients. But, it was recently observed that a big group of patients build up a resistance towards trastuzumab and lapatimib. HER2 receptors are known to endorse a specifically aggressive kind of cancer that affects an estimated thirty percent of breast cancer patients. The latest breast cancer vaccine is produced by the body's own cells. It gives a cancer fighting gene into cells, which then form immune system proteins and also tumour ? destroying cells.
According to the primary researcher Wei - Zen Wei, a professor of immunology and microbiology at the Karmanos Cancer Institute, the vaccine is made by using so - called naked DNA from genes that produces the HER2 receptor. This DNA is mixed with an immune stimulant. The process involved in the production of the vaccine, is named as electro oration.
In this method, pulses of electricity were used in order to inject the vaccine into the leg muscles in rats. The genes moved towards the cells, which then produced HER2 receptors that directed to activation of antibodies and immune cells called Killer T cells.
About the Author:
Jason Myers is a professional writer and he writes mostly about cancer cure research news. He's also interested in writing cancer information online.
No comments:
Post a Comment